October 21st 2020
Thorvardur Halfdanarson, MD, discusses the evolving role of immunotherapy in colorectal cancer.
September 3rd 2020
Thorvardur (Thor) Halfdanarson, MD, discusses investigational agents that are being evaluated in patients with colorectal cancer who do not harbor genomic alterations.
September 1st 2020
Thorvardur (Thor) Halfdanarson, MD, discusses the KEYNOTE-177 trial in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer.